Long non-coding RNA NEAT1 facilitates the growth, migration, and invasion of ovarian cancer cells via the let-7 g/MEST/ATGL axis

被引:0
作者
Lili Yin
Yu Wang
机构
[1] Shengjing Hospital of China Medical University,Department of Obstetrics and Gynecology
来源
Cancer Cell International | / 21卷
关键词
Ovarian cancer; Long non-coding RNA nuclear-enriched abundant transcript 1; microRNA let-7 g; Mesoderm specific transcript; Adipose triglyceride lipase; Migration; Apoptosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 179 条
[1]  
Bertucci A(2019)Tumor-targeting, MicroRNA-silencing porous silicon nanoparticles for ovarian cancer therapy ACS Appl Mater Interfaces 11 23926-23937
[2]  
Kim KH(2017)Ovarian cancer: epidemiology and risk factors Eur J Cancer Prev 26 55-62
[3]  
Kang J(2019)Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA-128 and modulating MAPK1 Mol Carcinog 58 577-587
[4]  
Zuidema JM(2017)Restoration of microRNA-708 sensitizes ovarian cancer cells to cisplatin via IGF2BP1/Akt pathway Cell Biol Int 41 1110-1118
[5]  
Lee SH(2019)MicroRNA-34 suppresses proliferation of human ovarian cancer cells by triggering autophagy and apoptosis and inhibits cell invasion by targeting Notch 1 Biochimie 160 193-199
[6]  
Kwon EJ(2017)Long Noncoding RNA and Cancer: A New Paradigm Cancer Res 77 3965-3981
[7]  
La Vecchia C(2020)Long noncoding RNA NEAT1/microRNA-125a axis predicts increased major adverse cardiac and cerebrovascular event risk independently in patients with unprotected left main coronary artery disease underwent coronary artery bypass grafting J Clin Lab Anal 34 e23299-2198
[8]  
Xu M(2018)Long non-coding RNA NEAT1 promoted ovarian cancer cells' metastasis through regulation of miR-382-3p/ROCK1 axial Cancer Sci 109 2188-1598
[9]  
Zhou K(2016)HuR-regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancer Cancer Med 5 1588-3357
[10]  
Wu Y(2020)Long noncoding RNA NEAT1 modifies cell proliferation, colony formation, apoptosis, migration and invasion via the miR4500/BZW1 axis in ovarian cancer Mol Med Rep 22 3347-339